Ganot Capital
VC Fund
Hollywood, United States
Ganot Capital is a VC fund in Hollywood focused on Health Care and Medical. Ganot is a privately held, family owned and operated, investment company that has over 50 years of healthcare investment experience. Ganot acquires and invests through buyouts, growth capital and venture capital. Ganot's portfolio spans across the senior care sector and includes real estate properties, healthcare service companies, medicaldevice companies and biopharmaceutical companies.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Ganot Capital invests in
Stages Ganot Capital invests in
Countries Ganot Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Guy Katsav
|
|||
4 more contacts available
Investment Focus
Industry
- Health Care 2 (67%)
- Medical 1 (33%)
- Biotechnology 1 (33%)
- Medical Device 1 (33%)
- Health Diagnostics 1 (33%)
Stage
- Series B 1 (33%)
- Series C 1 (33%)
- Series D 1 (33%)
Country
- Israel 1 (33%)
- United States 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Guy Katsav
Managing Director, Healthcare Investments
|
Managing Director, Healthcare Investments | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Notal Vision
|
Notal Vision is diagnostic services company to extend eye disease management from the clinic to the home and improve vision outcomes. | $60M / Series D / Jun 01, 2021 | |
Azura Ophthalmics
|
Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S. | $20M / Series C / Oct 22, 2020 | |
|
Azura Ophthalmics
|
Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S. | $16M / Series B / Oct 10, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Ganot Capital invest in?
Ganot Capital invests primarily in Health Care, Medical and Biotechnology startups, most often at Series B and Series C stage. Most of the 3 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Ganot Capital?
Public channels for Ganot Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Ganot Capital?
The team at Ganot Capital includes Guy Katsav (Managing Director, Healthcare Investments). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
